Kevin McKernan, an expert in mRNA technology, dives into the alarming connections between mRNA vaccines and emerging cancer cases. He discusses a significant Japanese study that highlights these trends and critiques the pharmaceutical industry's influence on health policy. The conversation moves on to mortality trends, advocating for data transparency to uncover potential vaccine-related health issues. McKernan also touches on the implications of cannabinoids as alternative therapies amid ongoing debates about public health and vaccine safety.